What is the recommended treatment for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Syphilis

Parenteral penicillin G is the preferred drug for treatment of all stages of syphilis, with the specific preparation, dosage, and duration determined by the stage of infection. 1

Treatment Regimens by Stage

Primary and Secondary Syphilis

  • Benzathine penicillin G, 2.4 million units IM in a single dose 2, 1
  • For children: Benzathine penicillin G, 50,000 units/kg IM, up to the adult dose of 2.4 million units in a single dose 2, 1

Early Latent Syphilis

  • Benzathine penicillin G, 2.4 million units IM in a single dose (same as primary/secondary) 1

Late Latent Syphilis or Latent Syphilis of Unknown Duration

  • Benzathine penicillin G, 7.2 million units total, administered as 3 doses of 2.4 million units IM each at 1-week intervals 1

Tertiary Syphilis

  • Benzathine penicillin G, 7.2 million units total, administered as 3 doses of 2.4 million units IM each at 1-week intervals 1

Alternative Treatments for Penicillin-Allergic Non-Pregnant Patients

  • For primary and secondary syphilis: Doxycycline 100 mg orally twice daily for 14 days 1, 3
  • For late latent syphilis or syphilis of unknown duration: Doxycycline 100 mg orally twice daily for 28 days 1, 3
  • Doxycycline appears to be an effective alternative with comparable serological response rates to penicillin in studies of early syphilis 4

Special Populations

Pregnant Women

  • Only penicillin G has documented efficacy for preventing maternal transmission 2, 1
  • Pregnant women with penicillin allergy should undergo desensitization and be treated with penicillin 2, 1

HIV-Infected Patients

  • Treatment regimens are the same as for non-HIV-infected patients 1
  • More frequent monitoring is recommended (at 3-month intervals instead of 6-month intervals) 3

Follow-Up and Monitoring

  • Quantitative nontreponemal serologic tests (VDRL or RPR) should be repeated at 6,12, and 24 months after treatment 1
  • A 4-fold decline in titer is expected within 6 months for primary/secondary syphilis and within 12-24 months for late syphilis 1
  • CSF examination is recommended if titers increase 4-fold, an initially high titer fails to decline at least 4-fold within appropriate timeframe, or neurological signs/symptoms develop 1

Management of Sex Partners

  • Persons exposed to a patient with primary, secondary, or early latent syphilis within the preceding 90 days should be treated presumptively, even if seronegative 2, 1
  • Persons exposed >90 days before diagnosis should be treated presumptively if serologic test results are not available immediately and follow-up is uncertain 2
  • Long-term sex partners of patients with late syphilis should be evaluated clinically and serologically 2, 1

Important Clinical Considerations

  • The Jarisch-Herxheimer reaction (acute febrile reaction with headache, myalgia) may occur within 24 hours after treatment, especially in early syphilis 2
  • Patients should be informed about this possible adverse reaction 2
  • In pregnant women, the Jarisch-Herxheimer reaction may induce early labor or cause fetal distress, but this concern should not prevent or delay therapy 2

Treatment Failure

  • Treatment failure is defined as failure of nontreponemal test titers to decline 4-fold within 6 months after therapy for primary or secondary syphilis 1
  • Re-treatment with weekly injections of benzathine penicillin G 2.4 million units IM for 3 weeks is recommended 1
  • CSF examination should be performed if treatment failure is suspected 2

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Syphilis in Non-Pregnant Individuals Allergic to Penicillin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Doxycycline compared with benzathine penicillin for the treatment of early syphilis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.